Terrie Curran
Chief Executive Officer bij PHATHOM PHARMACEUTICALS, INC.
Vermogen: 4 M $ op 31-03-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Frank Karbe | M | 56 | 8 jaar | |
| David Socks | M | 49 | 6 jaar | |
| Bhaskar Chaudhuri | M | 69 | 8 jaar | |
| James Topper | M | 62 | 6 jaar | |
| Patrick Heron | M | 53 | 8 jaar | |
| David Elkins | M | 55 | 6 jaar | |
| Mark Guinan | M | 62 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 jaar |
| Kathleen Sebelius | F | 74 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 jaar |
| Eric Venker | M | 37 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 7 jaar |
| Michael Cola | M | 64 | 5 jaar | |
| Todd Watanabe | M | 55 | 8 jaar | |
| Sue-Jean Lin | F | 65 | 3 jaar | |
| Howard Welgus | M | 72 | 8 jaar | |
| Asit Parikh | M | 52 | 5 jaar | |
| Heidi Fields | F | 69 | 5 jaar | |
| Chirfi Guindo | M | 58 | 13 jaar | |
| David C. Marek | M | 59 | 3 jaar | |
| Mark Stenhouse | M | 57 | 4 jaar | |
| Matthew Gline | M | 40 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 jaar |
| Azmi Nabulsi | M | 64 | 6 jaar | |
| Masaru Matsuda | M | 53 | 2 jaar | |
| Jay Ramsinghani | M | - | 4 jaar | |
| Neha Krishnamohan | F | 37 | 2 jaar | |
| Dalton Smart | M | 58 | 15 jaar | |
| Lene Skole-Sørensen | F | 65 | 9 jaar | |
| Ayisha Jeter | F | - | 4 jaar | |
| Halley Gilbert | F | 54 | 4 jaar | |
| Keith Leonard | M | 62 | 3 jaar | |
| Keith Manchester | M | 55 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 10 jaar |
| Adele Gulfo | F | 61 | 5 jaar | |
| Molly Henderson | F | 54 | 2 jaar | |
| Jeremy Levin | M | 70 | 7 jaar | |
| Frank Torti | M | 45 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 6 jaar |
| Lars Erik Holmqvist | M | 64 | 9 jaar | |
| Zachary Carpenter | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 jaar |
| Clarence Machado | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Allan Gabor | M | - | 11 jaar | |
| Charlotte Merritt | F | 61 | 7 jaar | |
| Nikhil Kehtarpal | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 5 jaar |
| George Bickerstaff | M | 68 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Eric Sciorilli | M | - | - | |
| Gillian Cannon | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 4 jaar |
| Ann Li Lee | M | 63 | 6 jaar | |
| Andrew Fromkin | M | 58 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 jaar |
| Nick Benedetto | M | - | - | |
| Richard Pulik | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 3 jaar |
| Timothy Nelson | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| David Berk | M | 45 | 5 jaar | |
| Tom Harris | M | - | - | |
| Richard DeLuca | M | 61 | 13 jaar | |
| Sakshi Chhabra | F | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Paul Davis | M | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 8 jaar |
| Kenneth Ludlum | M | 70 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Berndt A. E. Modig | M | 65 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Rakhi Kumar | F | 44 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | 9 jaar |
| Pierre Legault | M | 63 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Sanat Chattopadhyay | M | - | 15 jaar | |
| Atul Pande | M | 69 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Sef P. Kurstjens | M | 60 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
| Ilan Oren | M | 40 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jacqualyn Fouse | M | 62 | 7 jaar | |
| Robert Hugin | M | 69 | 19 jaar | |
| Fred Hassan | M | 78 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 6 jaar |
| Aditya Kohli | M | 36 | 2 jaar | |
| Lynn Seely | M | 65 | 5 jaar | |
| Tadataka Yamada | M | 77 | 3 jaar | |
| Sven Håkan Björklund | M | 68 | 5 jaar | |
| Timothy J. Smith | M | - | - | |
| Richard Clark | M | 77 | 6 jaar | |
| Scott Smith | M | 61 | 10 jaar | |
| Peter Kellogg | M | 67 | 5 jaar | |
| Scott Burrows | M | 47 | 4 jaar | |
| Thomas Daniel | M | 69 | 10 jaar | |
| Matthew Lang | M | 48 | - | |
| Joe Hand | M | - | 6 jaar | |
| Todd Branning | M | 54 | 1 jaar | |
| Michael Nally | M | 48 | 10 jaar | |
| Andreas Eggert | M | 56 | 5 jaar | |
| Thomas Perone | M | 59 | 12 jaar | |
| Brendan Delaney | M | 49 | 6 jaar | |
| Jens Jesper Ovesen | M | 67 | 3 jaar | |
| Jean-Marie Canan | M | 68 | 5 jaar | |
| Thomas Sabatino | M | 65 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 5 jaar |
| C. Nicholson | M | 68 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 4 jaar |
| Julie Gerberding | M | 69 | - | |
| Lawrence V. Stein | M | 74 | 3 jaar | |
| Susan Ellen Wolf | F | 69 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | 5 jaar |
| Kåre Schultz | M | 61 | 2 jaar | |
| Michael Bonney | M | 65 | 4 jaar | |
| Thomas Shenk | M | 77 | 11 jaar | |
| William Rastetter | M | 75 | 6 jaar | |
| Steven Goldstone | M | 78 | 6 jaar | |
| William N. Kelley | M | 84 | - | |
| John Weiland | M | 68 | 1 jaar | |
| Patricia Hemingway Hall | F | 71 | 1 jaar | |
| Rodman L. Drake | M | 80 | 8 jaar | |
| Ulf Arne Wiinberg | M | 66 | 6 jaar | |
| Melanie Lee | M | 65 | 3 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 85 | 86.73% |
| Bermuda | 9 | 9.18% |
| Denemarken | 9 | 9.18% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Terrie Curran
- Persoonlijk netwerk
